...
首页> 外文期刊>Saudi Journal of Anaesthesia >Use of transesophageal Doppler as a sole cardiac output monitor for reperfusion hemodynamic changes during living donor liver transplantation: An observational study
【24h】

Use of transesophageal Doppler as a sole cardiac output monitor for reperfusion hemodynamic changes during living donor liver transplantation: An observational study

机译:食管多普勒作为唯一心输出量监测器用于活体供肝移植期间再灌注血流动力学变化的观察性研究

获取原文
           

摘要

Aims: To report the use of transesophageal Doppler (TED), a minimally invasive cardiac output (COP) monitor, before, during and after reperfusion and study its effect on anesthetic management during living donor liver transplantation (LDLT). Setting and Design: A prospective observational study. Methods: A total of 25 consecutive recipients with a MELD score between 15 and 20 were enrolled. Data were recorded at baseline (TB); anhepatic phase (TA); and post-reperfusion — 1, 5, 10 and 30 minutes. Fluid therapy was guided by corrected flow time (FTc) of the TED. Packed red blood cells (RBCs) were only given when hematocrit was less than 25%. Rotational thromboelastometry (ROTEM) and standard laboratory tests were used to guide component blood products requirements. Results: Post-reperfusion, the COP, Cardiac Index (CI) and stroke volume (SV) increased significantly at all points of measurements; this was associated with a significant decrease in systemic vascular resistance (SVR) ( P ;< .05). Immediately post-reperfusion, for 5 minutes, mean arterial blood pressure (ABP) dropped significantly ( P < .05), and 14 out of the 25 patients required boluses of epinephrine (10 μ g) to restore the mean ABP; 3 of the 14 patients required norepinephrine infusion till the end of surgery. Central venous pressure (CVP) and urine output (UOP) at all measures were maintained adequately with FTc-guided fluid replacement. Eight out of the 25 patients required no blood transfusion, and 4 of the 8 patients required no catecholamine support. Conclusion: TED as a sole monitor for COP was able to present significant and reliable changes in the cardiovascular status of the recipients during reperfusion, which could help to guide fluid- and drug-supportive therapy in this population of patients. This preliminary study needs to be applied on a larger scale.
机译:目的:报告在再灌注之前,期间和之后使用微创心输出量(COP)监护仪经食道多普勒(TED)的情况,并研究其对活体供肝移植(LDLT)麻醉管理的影响。设置与设计:一项前瞻性观察研究。方法:共有25名MELD分数​​在15到20之间的连续接受者入组。数据记录在基线(TB)处;无肝期(TA);再灌注后-1、5、10和30分钟。流体治疗以TED的校正流动时间(FTc)为指导。仅在血细胞比容低于25%时才使用堆积的红细胞(RBC)。旋转血栓弹力测定法(ROTEM)和标准实验室测试被用来指导血液成分的要求。结果:再灌注后,所有测量点的COP,心脏指数(CI)和中风量(SV)均显着增加;这与全身血管阻力(SVR)的显着降低有关(P; <.05)。再灌注后5分钟,平均动脉血压(ABP)显着下降(P <.05),而25例患者中有14例需要大剂量肾上腺素(10μg)来恢复平均ABP; 14名患者中有3名需要去甲肾上腺素输注直至手术结束。在FTc引导下进行液体置换,所有措施的中心静脉压(CVP)和尿量(UOP)均保持足够。 25名患者中有8名不需要输血,而8名患者中有4名不需要儿茶酚胺支持。结论:TED作为COP的唯一监测器,能够在再灌注过程中显示接受者心血管状态的显着而可靠的变化,这可能有助于指导该人群的液体和药物支持治疗。这项初步研究需要大规模应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号